ESR1 and breast carcinoma: Another breast tumor database of gene expression from microarrays also showed that higher ATP5G1 expression was associated with reduced disease free survival (DFS, which is the same as RFS) in ERα+ breast cancer patients in Ireland (http://glados.ucd.ie/BreastMark/mRNA_analysis.html)49.